The global tissue banking equipment market was valued at USD 2.4 billion in 2025. The market is projected to grow from USD 2.65 billion in 2026 to USD 5.72 billion by 2034, exhibiting a compound annual growth rate of 10.1% during the forecast period. Contrive Datum Insights presents this information in its report titled "Tissue Banking Equipment Market Market Size, Share & Industry Analysis, By Type (Freezers, Storage System, Thawing Equipment, Labelling and Coding Equipment, Other), Application (Tissue Banks, Hospitals, Research and Academics Institutes, Diagnostic Laboratories, Other), Tissue type (Musculoskeletal Tissue, Ocular Tissue, Skin Tissue, Cardiovascular Tissue, Reproductive Tissue and Other), Technology (Cryopreservation, Controlled-Rate Freezing, Refrigerated / Non-Freezing Storage, Vitrification), Automation level (Manual Systems, Semi-Automated Systems, Automated Systems), and Regional Forecast, 2026-2034".
Tissue banking equipment covers the freezers, cryogenic and refrigerated storage systems, thawing units, and labelling and coding instruments used to preserve, track and retrieve donated human tissue, from bone and skin grafts to corneas and heart valves, between recovery and clinical use. It takes the form of ultra-low-temperature and liquid-nitrogen freezers, controlled-rate freezing chambers, vitrification units, barcode- and RFID-based labelling systems, and the racking and monitoring hardware that keeps a bank's inventory traceable. Buyers are accredited tissue banks, hospital tissue and transplant services, and the research institutes and diagnostic laboratories that process or study donated tissue under the same preservation and chain-of-custody requirements.
Cell and Gene Therapy Capacity Expansion
Cell and Gene Therapy Capacity Expansion is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 10.1% a year, the type lines exposed to it move fastest: Other compounds at 10.77%, taking its share of revenue from undefined% to undefined% and its value from USD 0.14 billion to USD 0.34 billion.
On the upside, the study's bull case assumes faster clinical adoption of cell and gene therapy pushes more tissue banks to expand cryogenic capacity sooner than the base case assumes, which would take 2034 revenue to USD 6.29 billion rather than the USD 5.72 billion base case.
However, capital budget constraints at hospital and regional tissue banks delay planned freezer and automation upgrades beyond the base case timeline, which would hold 2034 revenue to USD 5.15 billion. Storage System, which carries undefined% of 2025 revenue, already grows at only 9.72% against the market's 10.1%, so the largest part of the base is also its slowest.
Key Players Compete on Freezers Volume and Other Growth
Competition in the global tissue banking equipment market runs along the type axis rather than the regional one. Freezers holds undefined% of 2025 revenue at USD 0.91 billion and remains the largest line through 2034 at undefined%, making it the position hardest for a challenger to take. Other, growing at 10.77%, is where share actually changes hands. A supplier established in one is not thereby established in the other, which is what sustains a field of this size in a market of USD 2.4 billion.
Further Report Findings
- Based on regional analysis, North America led the global tissue banking equipment market in 2025 with undefined% of global revenue at USD 0.96 billion, reaching USD 2.06 billion by 2034.
- Middle East and Africa remains the smallest region throughout, at undefined% of 2025 revenue and undefined% by 2034.
- On the basis of type, Freezers held the dominant share of the market in 2025 at undefined%, worth USD 0.91 billion.
- Other is projected to grow at 10.77% over the forecast period, the fastest of any type line.
- By application, Tissue Banks led in 2025 with undefined% of revenue at USD 0.84 billion, while Research and Academics Institutes grows fastest at 11.41%.
- By tissue type, Musculoskeletal Tissue led in 2025 with undefined% of revenue at USD 0.77 billion, while Cardiovascular Tissue grows fastest at 11.11%.
- By technology, Cryopreservation led in 2025 with undefined% of revenue at USD 1.08 billion, while Vitrification grows fastest at 12.45%.
- By automation level, Manual Systems led in 2025 with undefined% of revenue at USD 0.96 billion, while Automated Systems grows fastest at 13.52%.
- the United States is the largest single country market at USD 0.84 billion in 2025, 35% of global revenue.
The report segments the market across five axes; by type, and by application, tissue type, technology and automation level; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 5.15 billion and USD 6.29 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.